nature's tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide reduces food intake and

Research on the gut microbiome in patients (male and female) with metabolic diseases, such as obesity 154 and type 2 diabetes 35,155 , has reported a reduction of riboflavin synthesis genes in their gut metagenome

However, weight loss induced by GLP-1RAs encompasses both fat and lean tissue compartments and could be associated to nutritional deficiencies, raising important questions regarding their impact on skeletal muscle, particularly in individuals at increased risk of sarcopenia [11]

doi 10.14309/crj.0000000000001544 108 CalvaryskyBDotanIShepshelovichDLeaderACohenTD

Close coordination with your endocrinologist or diabetes care provider is essential

Because of this shortage, licensed compounding pharmacies can produce compounded versions of tirzepatide to help maintain patient access